baber/WOPTO huggingface dataset:
Patent NZ-534238-A (NZ)
Title: Compounds that inhibit factor Xa activity
Inventor: ECKL ROBERT
IPC: A61P7/00
Filed: 2003-01-31
Abstract: Disclosed are compounds of formula (I), wherein: A is H, a group of formula -C(=NR4)NH2, or is together with one of R1, part of a 5- or 6- membered heteroaryl or heterocycloalkyl ring, a group of formula -NHC(=NR4)NH2, or has one formulae (II) or (III), Ar1 is aryl, heteroaryl, or heteroaralkyl group, Ar2 is an aryl, aralkyl, heteroaryl, or heteroaralkyl group, and the remaining substituents are defined herein. The compounds are used for the medicaments for inhibiting factor Xa.
Patent NZ-535461-A (NZ)
Title: Antisense IAP nucleobase oligomers and uses thereof
Inventor: LACASSE ERIC
IPC: A61K31/711
Filed: 2003-03-27
Abstract: The present invention features nucleobase oligomers that hybridize to IAP polynucleotides, and methods for using them to enhance apoptosis and treat proliferative diseases.
Patent NZ-536583-A (NZ)
Title: A conductor polymer backfill composition and method of use as a reinforcement material for utility poles
Inventor: HANNAY RICHARD C
IPC: E02D27/44
Filed: 2003-05-08
Abstract: Disclosed is a method of setting or resetting a pole or a structure in earth with a polymer composition, comprising forming the composition, dispersing a conductive material throughout the polymer composition, and applying the polymer composition to the pole or structure, for uses including grounding buildings such as substations. In particular is a foamed conductive polymer composition, comprising: A polyisocyanate, an organic alcohol component, an asphaltic component, a liquid water-immiscible component, a catalyst, a non-ionic surfactant, a flame retardant and a conductive material dispersed throughout the composition.
Patent NZ-538608-A (NZ)
Title: Detecting cytosine methylation in genomic DNA samples in which all unmethylated cytosine bases are converted to uracil and the 5-methylcytosine bases remain unchanged
Inventor: OLEK ALEXANDER
Filed: 2002-03-08
Abstract: A method for the detection of cytosine methylation in DNA samples is described, characterized in that the following steps are conducted: a genomic DNA sample, which comprises the DNA to be investigated as well as background DNA is chemically treated in such a way that all of the unmethylated cytosine bases are converted to uracil, while the 5-methylcytosine bases remain unchanged; the chemically treated DNA sample is amplified with the use of at least two primer oligonucleotides as well as a polymerase, whereby the DNA to be investigated is preferred over the background DNA as the template, and whereby the amplification is not conducted in the presence of additional oligonucleotides or a PNA oligomers, which preferably bind to 5'-CG-3' dinucleotides or a 5'-TG-3' dinucleotides or 5'-CA-3' dinucleotides of the background DNA and adversely affect its amplification, and the amplified products are analyzed and the methylation status in the DNA to be investigated is concluded from analysis of additional positions.
Patent NZ-539347-A (NZ)
Title: Novel bicyclic inhibitors of hormone sensitive lipase
Inventor: PETRY STEFAN
Filed: 2003-09-27
Abstract: Benzotriazoles of formula (I) which show an inhibitory effect on hormone sensitive lipase are disclosed, wherein R1 to R8 and n are as defined in the specification. A process for the preparation of these benzotriazoles of formula (I) is also disclosed. These compounds are suitable for the treatment of non-insulin-dependent diabetes mellitus, diabetic syndrome and syndrome X.
Patent NZ-540277-A (NZ)
Title: Double cross parallel binder fabric
Inventor: FAHRER ERNEST
IPC: D21F1/00
Filed: 2003-12-15
Abstract: A multi-layer fabric which may be utilized in a papermaking process. Such fabric has a first layer having machine direction (MD) yarns and cross-direction (CD) yarns interwoven therewith and a second layer having machine direction (MD) yarns and cross-direction (CD) yarns interwoven therewith. In such fabric, a plurality of pairs of first type of binders each having a first binder and a second binder are interwoven with the first and second layers. The first and second binders of at least one pair are interwoven with the first and second layers so as to pass over at least one same yarn on an outer surface of the first layer.
Patent NZ-540814-A (NZ)
Title: Cord adjuster
Inventor: LUNDSTEDT KURT
IPC: F16G11/10
Filed: 2005-06-17
Abstract: An adjuster for a cord includes a first end and a second end and the adjuster can be translated between a first and a second position. The first end can be attached to a looped member such as a belt and the looped member can be attached to a support surface. The adjuster includes a tortuous path configured to accept the cord. When the cord is inserted, the tortuous path divides the cord into a first portion and a second portion. When tension is applied to the second portion of the cord, the resultant friction forces exceed the tension force such that the position of the cord in the adjuster is maintained while the adjuster is in the first position. A force exerted on the second end of the adjuster can translate the adjuster to the second position where the friction force exerted by the tortuous path is substantially reduced such that the cord can be repositioned be exerting tension on either the first or the second portion of the cord. When the adjuster is returned to the first position, the application of tension to the second portion of the cord will again cause the adjuster to maintain the position of the cord.
Patent NZ-541253-A (NZ)
Title: Peptide binding agents which inhibit myostatin
Inventor: MIN HOSUNG
IPC: A61K38/08
Filed: 2003-12-19
Abstract: Disclosed is a binding agent comprising at least one peptide capable of binding myostatin, wherein the peptide comprises the sequence Cb1b2Wb3WMCPP (SEQ ID NO: 353), wherein b1 is selected from any one of the amino acids T, I, or R; b2 is selected from any one of R, S, Q; b3 is selected from any one of P, R and Q, wherein the peptide is between 10 and 50 amino acids in length, and physiologically acceptable salts thereof. The binding agents of the present invention can be used to increase lean muscle mass and decrease fat to muscle ratios. Therapeutic compositions containing the binding agents of the present invention are useful for treating muscle-wasting disorders and other metabolic disorders including diabetes and obesity.
Patent NZ-542154-A (NZ)
Title: Nozzles for producing flat spray patterns
Inventor: DODSON MITCHELL JOE
IPC: F25C3/04
Filed: 2004-04-02
Abstract: Various nozzles(10) for producing a flat spray pattern are disclosed. The nozzle has a fluid passageway terminating in a cross member having an end wall having an outlet aperture (20), the fluid passageway having at least two deflectors (3, 4) that deflect the fluid towards the aperture. There are adjustable means (21, 22) to vary the cross-section of the aperture. The nozzles may be used in snowmaking equipment.
Patent NZ-549944-A (NZ)
Title: Dietary supplement and method for treating digestive system-related disorders
Inventor: BEDDING PETER M J
IPC: A23K20/195
Filed: 2004-11-03
Abstract: Disclosed is a dietary supplement for the treatment and prevention of digestive system-related disorders, said digestive supplement comprising: polar lipid supplement that has been isolated form its natural source which polar lipid supplement contains significant amounts of polar lipids and antioxidants; a soluble beta-glucan fiber source that has been fractionated from its natural origin which soluble beta-glucan fiber source provides at least one beneficial effect on health; and at least one amino acid that provides at least one beneficial effect on a digestive system.
Patent NZ-550416-A (NZ)
Title: Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
Inventor: WILSON JAMES M
IPC: A61K48/00
Filed: 2002-11-20
Abstract: A vector which comprises an adenovirus capsid where the capsid comprises a simian adenoviral Pan-6 hexon protein having the amino acid sequence of SEQ ID NO:7, or a sequence having at least 95-99% identity with SEQ ID NO:7 or a functional fragment thereof. The vector further comprises a heterologous gene operatively linked to sequences which direct expression of the gene in a host cell.
Patent NZ-551636-A (NZ)
Title: Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
Inventor: CURAUDEAU ALAIN H
IPC: A61P17/00
Filed: 2005-02-08
Abstract: Disclosed is the use of a photosensitiser selected from benzoporphyrin derivatives, green porphyrins or combinations thereof in the preparation of a medicament for the treatment of a hyperactive sebaceous gland disorder other than acne.
Patent NZ-552814-A (NZ)
Title: Fire protection
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2003-02-07
Abstract: A wind power installation comprises a pylon 10 and a pod 12 arranged at the top of the pylon 10. Apparatus is provided for producing an inert atmosphere in the pylon 10 and/or in the pod 12, or other parts of the wind power installation, and closable ventilation openings are provided in the pylon 10 and/or the pod 12 of the wind power installation and/or an annex building.
Patent NZ-555334-A (NZ)
Title: Method of treatment or prophylaxis of a neuropathic condition using AT2 receptor antagonist
Inventor: SMITH MAREE THERESE
IPC: A61K38/08
Filed: 2005-12-23
Abstract: Disclosed is an AT2 receptor antagonist compound of formula I wherein the substituents are disclosed within the specification, or a pharmaceutically compatible salt thereof. Also disclosed is the use of the compound of formula I for treating neuropathic pain.
Patent NZ-555684-A (NZ)
Title: Hydantoin derivatives useful as metalloproteinase inhibitors
Inventor: WATERSON DAVID
IPC: C07D401/12
Filed: 2005-12-14
Abstract: Disclosed is a compound of formula (I), or a pharmaceutically acceptable salts thereof, wherein R1 is C2-4alkyl and is substituted by two or more fluorine groups, and R2 is methyl or ethyl. Also disclosed is a process for preparing the compound, and the use of the compound for treating conditions mediated by one or more metalloproteinase enzymes or by collagenase 3, such as osteoarthritis or rheumatoid arthritis.
Patent NZ-556142-A (NZ)
Title: Animal remedy dispensing means
Inventor: EBBETT TODD DONALD
IPC: F16K21/00
Filed: 2007-06-25
Abstract: An animal remedy dispensing means (100) is described which has an elongate handle (10) having a longitudinal axis (A), an inlet (14) for receiving a remedy and an outlet aperture (21). The outlet has a central axis (B) which forms an angle (8) of between 0 degrees and 45 degrees with the longitudinal axis (A) of the handle. The dispensing means includes a barrel (11) and a plunger (12) reciprocable within the barrel upon relative movement of the handle and a flow control member (13), the barrel provided with an inlet port in fluid communication with the inlet, and an outlet port in fluid communication with the outlet aperture, wherein a central axis of the barrel and the longitudinal axis of the first handle form an angle of between 70 degrees and 90 degrees. The dispensing means includes a dosage control part (39) which is moveable between a first position wherein the dose dispensed can be adjusted and a second position wherein the dose dispensed cannot be adjusted.
Patent NZ-560264-A (NZ)
Title: 2-sulfinyl-and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
Inventor: ALBRECHT WOLFGANG
IPC: A61K31/435
Filed: 2006-02-27
Abstract: The disclosure relates to 2-sulfinyl- or 2-sulfonyl-substituted imidazole derivatives of the formula (I) in which the radicals R1, R2, R3 and R4 have the meaning indicated in the description. These compounds have an immunomodulating and/or cytokine release-inhibiting effect and are therefore suitable for the treatment of disorders associated with an impairment of the immune system.
Patent NZ-561234-A (NZ)
Title: Pressure toilet with bulk loading siphon assist
Inventor: KURU WILLIAM C
IPC: E03D11/02
Filed: 2006-03-03
Abstract: A pressure toilet (10) has a trapway (18) providing 'as needed' (bulk dependent) siphon assist. During normal liquid waste or low bulk flushing, no siphon is formed in the trapway, and the water and light waste in the bowl are evacuated solely under the force of the pressurized jet of water. A large volume (30) near or just downstream from the dam (28) is provided to accommodate the blow out from the water jet. Only upon reaching a threshold concentration of bulk waste material in the down leg (32) does the trapway draw a siphon. A horizontal baffle (36) at the lower part of the down leg assists in the accumulation of bulk material of sufficient concentration to establish a siphon in the trapway.
Patent NZ-562427-A (NZ)
Title: Process for making Si-H functional siloxane oligomer
Inventor: RUBINSZTAJN SLAWOMIR
IPC: C07F7/08
Filed: 2006-04-12
Abstract: Disclosed is a process for making a Si-H functional siloxane oligomer, the process comprising the steps of: · providing a silicon hydride or Si-H functional siloxane; · providing a cyclic siloxane oligomer; and · providing a Lewis acid that is capable of interacting with the hydrogen of the silicon hydride to promote the ring opening of the cyclic siloxane oligomer thereby facilitating the insertion of polysiloxane segment between Si and H atoms to form the Si-H functional siloxane oligomer.
Patent NZ-570225-A (NZ)
Title: Panel mount
Inventor: ALLEN WARWICK JAMES
IPC: E04F11/18
Filed: 2007-07-03
Abstract: A panel mount 1 for non penetrative fastening of a panel, the panel mount comprising clamp jaws 3 4 defining an elongate slot in which an edge of a panel can be received, a foot 12 for mounting and fastening the clamp jaws 3 4 to a structure, each clamp jaw 3 4 carrying at least one threaded fastener 21 that can be actuated by a user, including when the foot 12 is fastened to the structure, the threaded fastener(s) 21 of each clamp jaw 3 4, in cooperation with the or each other threaded fastener 21, capable of operatively clamping the panel to hold it in the slot, irrespective of any non-parallel disposition of the plane of the panel to the elongate direction of the slot.
Patent NZ-570942-A (NZ)
Title: A catheter assembly with members on the distal end that extend radially to expose electrodes
Inventor: ANDERSON NEIL LAWRENCE
IPC: A61B18/14
Filed: 2008-09-02
Abstract: A catheter sheath (10) is disclosed. The sheath (10) is able to open up and expose electrodes (22, 64) previously concealed. The sheath (10) includes an elongate element (12) defining a primary lumen and a plurality of secondary lumens arranged in spaced relationship about the primary lumen. A plurality of discrete members or petals (14) are arranged at the end of the elongate element (12), the discrete members (14) being defined by a plurality of circumferentially spaced, longitudinally extending slits at the end of the elongate element that separate the members from each other. The discrete members (14) also carry the secondary lumens and continue to define the primary lumen when in a first position. The discrete members (14) are displaceable using pull wires, between the first position which extends parallel to a longitudinal axis of the elongate element (12) and a second position in which the discrete members extend transversely to the longitudinal axis of the elongate element (12). At least one electrode (22) is carried by at least one of the discrete members (14). The electrical conductors (64) for the at least one electrode is arranged in the primary lumen, the primary lumen being shaped to accommodate the conductors.
Patent NZ-579269-A (NZ)
Title: Endpoint meter which can transition from a mobile mode to a fixed wireless network mode
Inventor: SHUEY KENNETH C
IPC: G01D4/00
Filed: 2008-03-07
Abstract: A system comprising a plurality of endpoint meters, an electrical energy meter, and a method of operating an endpoint meter is disclosed. The plurality of endpoint meters gather and transmit meter data, where at least some of the endpoint meters operate in a fixed network mode in which the meters communicate with each other to form a fixed wireless network, and at least some other of the meters operate in a mobile mode. The meters transmit meter data to a mobile collector where each meter is reconfigurable to operate in a selected one of the fixed network mode and the mobile mode. The mobile collector receives meter data from the meters that are operating in the mobile mode.
Patent NZ-583545-A (NZ)
Title: Phosphadiazine hcv polymerase inhibitors iv
Inventor: DOUSSON CYRIL
IPC: A61K31/4025
Filed: 2008-08-28
Abstract: Disclosed are phosphadiazine compounds of Formula IV', where the substituents are as defined herein. Also disclosed is a pharmaceutical composition which comprises a compound as defined above and one or more pharmaceutically acceptable carriers, and which may also optionally comprise a second antiviral agent such as an interferon; for the treatment of a liver disease or a disorder associated with an Hepatitis C viral (HCV) infection.
Patent NZ-585798-A (NZ)
Title: Indolinone derivatives and process for their manufacture
Inventor: MERTEN JOERN
IPC: C07D209/34
Filed: 2008-12-02
Abstract: Disclosed herein are specific indolinone derivatives as depicted by compounds of the given formula, wherein the substituents are as defined within the specification. Also disclosed are improved processes for the manufacture of said compounds, which are useful as intermediates in the synthesis of drug substances useful in treating oncological or non-oncological diseases.
Patent NZ-592333-A (NZ)
Title: Electronic detonator system
Inventor: LOESER RONALD L
IPC: F42D1/055
Filed: 2009-10-23
Abstract: Disclosed is an electronic detonator (10) with a detonator (10) housing that integrally packages a chip with a high voltage switch having a first switch contact spaced from and electrically isolated from a second switch contact and a trigger element. The trigger element passes between and is spaced from the first switch contact and the second switch contact and is shaped as a repeating pattern of faceted sections that narrow in width and funnel out in width. The detonator (10) also has an initiator (14) connected in series to the first switch contact of the high voltage switch thus forming a series circuit between the initiator (14) and the high voltage switch, an initiating pellet positioned relative to the initiator (14) such that functioning of the initiator (14) causes detonation of the initiating pellet, a primary energy source (48), a secondary energy source (50) and a controller operatively configured to function the initiator (14) to detonate the initiating pellet. The initiating is completed by controlling the primary energy source (48) to apply a desired primary charge potential to the series circuit including the initiator (14) and the high voltage switch and the secondary energy source (50) to drive a current through the trigger element that is sufficient to close the high voltage switch by electrically connecting the first switch contact to the second switch contact.
Patent NZ-596732-A (NZ)
Title: Process for the production of dronedarone intermediates
Inventor: KRETZSCHMAR GERHARD
IPC: C07D307/80
Filed: 2010-05-26
Abstract: A process for the production of Dronedarone intermediates of the formula (I), by acylation of 2-(2-hydroxy-5-nitrophenyl)-1-(4-methoxyphenyl)-ethanone, subsequent treatment of the ester with bases and a zeolite (alumosilicate) catalyst and optional subsequent demethylation. This process can be used for the production of Dronedarone.
Patent NZ-598484-A (NZ)
Title: Use of aerosolized levofloxacin for treating cystic fibrosis
Inventor: LOUTIT JEFFEREY S
IPC: A61P11/00
Filed: 2010-09-03
Abstract: 598484 The disclosure relates to the use of an aerosol of a solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation in the manufacture of a medicament for the treatment of cystic fibrosis in a human, where the human has a pulmonary infection comprising Pseudomonas aeruginosa and the medicament is formulated for use in a method comprising the steps of determining a dose of the medicament to achieve an increase in a CFQ-R respiratory domain greater than 1 and repeatedly administering the dose to the human having cystic fibrosis to treat the pulmonary infection.
Patent NZ-598518-A (NZ)
Title: Concentrated polypeptide formulations with reduced viscosity
Inventor: KAMERZELL TIM
IPC: A01N25/26
Filed: 2010-08-03
Abstract: Disclosed is a liquid formulation comprising (a) an antibody in an amount of greater than about 50 mg/mL and (b) dimethyl sulfoxide (DMSO) or dimethylacetamide (DMA) in an amount of between about 0.1% to about 50% v/v of the formulation, wherein the formulation has reduced viscosity compared to the same formulation in the absence of DMSO or DMA.
Patent NZ-603057-A (NZ)
Title: Database management system
Inventor: STARKEY JAMES A
IPC: G06F17/30
Filed: 2011-03-18
Abstract: A database management system that enables users to interact with a database comprised of data and metadata is disclosed. The system comprises a plurality of nodes; means connected to the plurality of nodes for providing communications paths between all the nodes, and means connected to the communications means for providing persistent storage with a copy of each atom whereby the collection of information in the atoms received in persistent storage contains all the data and metadata in the database. Each node comprises i) an interface between high level-input and output commands at a user level and input and output commands at the system level that control a sequence of operations for interacting with the data base, wherein, in response to certain system level commands, atoms are generated based upon atom objects, each atom containing a specified fragment of data or metadata; ii) a communications control for establishing a communications path with each other node in the system; iii) a method responsive to a system command from the interface for requesting from a selected node copy of an atom that is relevant to the query but is not present in that node; iv) a method responsive to a request for an atom from another node for replicating the requested atom for transfer to the requesting node whereby only atoms required to complete a query need be located in any transaction node at any given time, and v) a method responsive to a change in an atom at that node for replicating that atom for transfer to every other node in the system in which that atom is resident.
Patent NZ-616379-A (NZ)
Title: Building construction
Inventor: PERREN NICOLAS JEAN PAUL
IPC: E04H1/12
Filed: 2012-03-22
Abstract: A building system comprising a container 10 comprising a floor, side walls 56 and a roof 46, where the floor has opposite side edges and the roof has opposite guttered side edges, and where the side walls consist of a single pair of opposed side walls 56 each having a height, a plurality of pairs of hinges 52, and a plurality of pairs of roof sections 66, where each roof section has a span greater than the height of each side wall 56. The pair of opposed, side walls are adapted to fold downwardly from the opposite side edges of the floor to form a pair of floor sections abutting opposite sides of the floor of the container. The opposite guttered side edges of the roof are adapted to mount the plurality of pairs of hinges 52 spaced apart from one another. The plurality of pairs of hinges 52 are adapted to mount the plurality of pairs of roof sections to pivot upwardly to overlap both the plurality of pairs of hinges, and the opposite guttered side edges of the roof of the container.